NOT KNOWN FACTUAL STATEMENTS ABOUT PHENOBARBITAL SODIUM DRUG CLASS

pentobarbital will lower the extent or effect of mestranol by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.Contraindicated (1)pentobarbital will minimize the extent or effect of cariprazine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. CYP3A4 is liable for the development and elimination of